These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 8572569
1. Contrasting patterns of selenium excretion by female CD rats treated with chemically related chemopreventive organic selenocyanate compounds. Sohni OS, Li H, Surace A, el-Bayoumy K, Upadhyaya P, Fiala ES. Anticancer Res; 1995; 15(5B):1849-56. PubMed ID: 8572569 [Abstract] [Full Text] [Related]
2. Comparative excretion and tissue distribution of selenium in mice and rats following treatment with the chemopreventive agent 1,4-phenylenebis(methylene)selenocyanate. Sohn OS, Desai DH, Das A, Rodriguez JG, Amin SG, El-Bayoumy K. Chem Biol Interact; 2005 Feb 10; 151(3):193-202. PubMed ID: 15733540 [Abstract] [Full Text] [Related]
3. Excretion and tissue distribution of selenium following treatment of male F344 rats with benzylselenocyanate or sodium selenite. Sohn OS, Blackwell L, Mathis J, Asaad WW, Reddy BS, el-Bayoumy K. Drug Metab Dispos; 1991 Feb 10; 19(5):865-70. PubMed ID: 1686229 [Abstract] [Full Text] [Related]
6. 1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Tanaka T, Makita H, Kawabata K, Mori H, El-Bayoumy K. Cancer Res; 1997 Sep 01; 57(17):3644-8. PubMed ID: 9288763 [Abstract] [Full Text] [Related]
7. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, El-Bayoumy K, Reddy BS. Cancer Res; 2001 May 01; 61(9):3647-52. PubMed ID: 11325834 [Abstract] [Full Text] [Related]
8. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Shimada T, El-Bayoumy K, Upadhyaya P, Sutter TR, Guengerich FP, Yamazaki H. Cancer Res; 1997 Nov 01; 57(21):4757-64. PubMed ID: 9354437 [Abstract] [Full Text] [Related]
9. Comparative effects of phenylenebis(methylene)selenocyanate isomers on xenobiotic metabolizing enzymes in organs of female CD rats. Sohn OS, Fiala ES, Upadhyaya P, Chae YH, El-Bayoumy K. Carcinogenesis; 1999 Apr 01; 20(4):615-21. PubMed ID: 10223189 [Abstract] [Full Text] [Related]
11. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Samaha HS, Hamid R, el-Bayoumy K, Rao CV, Reddy BS. Cancer Epidemiol Biomarkers Prev; 1997 Sep 01; 6(9):699-704. PubMed ID: 9298577 [Abstract] [Full Text] [Related]
12. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention. Ip C, el-Bayoumy K, Upadhyaya P, Ganther H, Vadhanavikit S, Thompson H. Carcinogenesis; 1994 Feb 01; 15(2):187-92. PubMed ID: 8313507 [Abstract] [Full Text] [Related]
13. Synthesis and excretion profile of 1,4-[14C]phenylenebis(methylene)selenocyanate in the rat. El-Bayoumy K, Upadhyaya P, Sohn OS, Rosa JG, Fiala ES. Carcinogenesis; 1998 Sep 01; 19(9):1603-7. PubMed ID: 9771931 [Abstract] [Full Text] [Related]
14. Inhibition of nuclear factor-kappaB DNA binding by organoselenocyanates through covalent modification of the p50 subunit. Chen KM, Spratt TE, Stanley BA, De Cotiis DA, Bewley MC, Flanagan JM, Desai D, Das A, Fiala ES, Amin S, El-Bayoumy K. Cancer Res; 2007 Nov 01; 67(21):10475-83. PubMed ID: 17974991 [Abstract] [Full Text] [Related]
15. Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray. El-Bayoumy K, Narayanan BA, Desai DH, Narayanan NK, Pittman B, Amin SG, Schwartz J, Nixon DW. Carcinogenesis; 2003 Sep 01; 24(9):1505-14. PubMed ID: 12844480 [Abstract] [Full Text] [Related]
16. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer. El-Bayoumy K, Das A, Narayanan B, Narayanan N, Fiala ES, Desai D, Rao CV, Amin S, Sinha R. Carcinogenesis; 2006 Jul 01; 27(7):1369-76. PubMed ID: 16399772 [Abstract] [Full Text] [Related]
17. Comparative action of 1,4-phenylenebis(methylene)selenocyanate and its metabolites against 7,12-dimethylbenz[a]anthracene-DNA adduct formation in the rat and cell proliferation in rat mammary tumor cells. El-Bayoumy K, Das A, Boyiri T, Desai D, Sinha R, Pittman B, Amin S. Chem Biol Interact; 2003 Oct 25; 146(2):179-90. PubMed ID: 14597131 [Abstract] [Full Text] [Related]
18. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. El-Bayoumy K, Sinha R. Mutat Res; 2004 Jul 13; 551(1-2):181-97. PubMed ID: 15225592 [Abstract] [Full Text] [Related]
19. Comparison of the chemopreventive efficacies of 1,4-phenylenebis(methylene)selenocyanate and selenium-enriched yeast on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mouse. Das A, Desai D, Pittman B, Amin S, El-Bayoumy K. Nutr Cancer; 2003 Jul 13; 46(2):179-85. PubMed ID: 14690794 [Abstract] [Full Text] [Related]
20. Subchronic toxicity of benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate in F344 rats. Conaway CC, Upadhyaya P, Meschter CL, Kurtzke C, Marcus LA, el-Bayoumy K. Fundam Appl Toxicol; 1992 Nov 13; 19(4):563-74. PubMed ID: 1426715 [Abstract] [Full Text] [Related] Page: [Next] [New Search]